Interleukin‐1 blockade in heart failure: an on‐treatment and off‐treatment cardiorespiratory fitness analysis

AIMS: Interleukin‐1 (IL‐1) blockade may improve exercise capacity in patients with heart failure (HF) patients. The extent of the improvement and its persistence beyond discontinuation of IL‐1 blockade is unknown. METHODS AND RESULTS: The primary objective was to determine changes in cardiorespirato...

Descripción completa

Detalles Bibliográficos
Autores principales: Moroni, Francesco, Golino, Michele, Carbone, Salvatore, Trankle, Cory, Del Buono, Marco Giuseppe, Talasaz, Azita, Arena, Ross, Canada, Justin M., Biondi‐Zoccai, Giuseppe, Van Tassel, Benjamin, Abbate, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567671/
https://www.ncbi.nlm.nih.gov/pubmed/37403287
http://dx.doi.org/10.1002/ehf2.14460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567671/
https://www.ncbi.nlm.nih.gov/pubmed/37403287
http://dx.doi.org/10.1002/ehf2.14460

Ejemplares similares